These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7039315)

  • 1. Functional bacterial opsonic activity of human amniotic fluid.
    Cone MJ; Steele RW; Marmer DJ; Hill DE
    Am J Obstet Gynecol; 1982 Feb; 142(3):282-7. PubMed ID: 7039315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci.
    Shyur SD; Raff HV; Bohnsack JF; Kelsey DK; Hill HR
    J Immunol; 1992 Mar; 148(6):1879-84. PubMed ID: 1541826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates.
    Källman J; Schollin J; Schalèn C; Erlandsson A; Kihlström E
    Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F46-50. PubMed ID: 9536841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid detection of group B streptococcus and Escherichia coli in amniotic fluid using real-time fluorescent PCR.
    Straka M; Dela Cruz W; Blackmon C; Johnson O; Stassen S; Streitman D; Golden S; Stamilio D
    Infect Dis Obstet Gynecol; 2004; 12(3-4):109-14. PubMed ID: 15763909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid in vitro replication of group B streptococcus in term human amniotic fluid.
    Hemming VG; Nagarajan K; Hess LW; Fischer GW; Wilson SR; Thomas LS
    Gynecol Obstet Invest; 1985; 19(3):124-9. PubMed ID: 3894177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of meconium staining of amniotic fluid on the growth of Escherichia coli and group B streptococcus.
    Eidelman AI; Nevet A; Rudensky B; Rabinowitz R; Hammerman C; Raveh D; Schimmel MS
    J Perinatol; 2002 Sep; 22(6):467-71. PubMed ID: 12168124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW; Wilson SR; Hunter KW
    J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opsonic activity of normal human cerebrospinal fluid for selected bacterial species.
    Tofte RW; Peterson PK; Kim Y; Quie PG
    Infect Immun; 1979 Dec; 26(3):1093-8. PubMed ID: 43289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of group B streptococcal opsonins in human and rabbit serum by neutrophil chemiluminescence.
    Hemming VG; Hall RT; Rhodes PG; Shigeoka AO; Hill HR
    J Clin Invest; 1976 Dec; 58(6):1379-87. PubMed ID: 62761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of nonspecific (alternative pathway) opsonic activity by neutrophil chemiluminescence.
    Hill HR; Hogan NA; Bale JF; Hemming VG
    Int Arch Allergy Appl Immunol; 1977; 53(6):490-7. PubMed ID: 405330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
    Givner LB
    Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.
    van Furth R; Leijh PC; Klein F
    J Infect Dis; 1984 Apr; 149(4):511-7. PubMed ID: 6202804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of fibronectin on the interaction of polymorphonuclear leukocytes with unopsonized and antibody-opsonized bacteria.
    Yang KD; Augustine NH; Gonzalez LA; Bohnsack JF; Hill HR
    J Infect Dis; 1988 Oct; 158(4):823-30. PubMed ID: 2844920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus.
    Butko P; Nicholson-Weller A; Wessels MR
    J Immunol; 1999 Sep; 163(5):2761-8. PubMed ID: 10453019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
    Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
    Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A human IgG 3 is opsonic in vitro against type III group B streptococci.
    Kim JS; Kim KS; Wass CA; Short JA; Heiner DC
    J Clin Immunol; 1990 May; 10(3):154-9. PubMed ID: 2195055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli.
    Rozenberg-Arska M; Porsius JC; Jaarsma EY; Verhoef J
    J Med Microbiol; 1986 Sep; 22(2):143-9. PubMed ID: 3528498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of group B streptococcal antigens in amniotic fluid of rhesus monkeys.
    Hemming VG; London WT; Smith LP; Curfman BL; Fischer GW; Sever JL
    J Clin Microbiol; 1983 Jun; 17(6):1127-31. PubMed ID: 6348078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonic and protective activity of immunoglobulin, modified immunoglobulin, and serum against neonatal Escherichia coli K1 infection.
    Bortolussi R; Fischer GW
    Pediatr Res; 1986 Feb; 20(2):175-8. PubMed ID: 3511443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonic activity of sera and blister fluid from severely burned patients evaluated by a chemiluminescence method.
    Ono Y; Kunii O; Suzuki H; Ikeda H; Kobayashi K; Kanegasaki S
    Microbiol Immunol; 1994; 38(5):373-7. PubMed ID: 7935062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.